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Abstract
Background Laparoscopic sleeve gastrectomy (LSG) and
laparoscopic gastric bypass (LRYGB) are most commonly
performed bariatric procedures. Laparoscopic approach
and enhanced recovery after surgery (ERAS) protocols
managed to decrease length of hospital and morbidity.
However, there are patients in whom, despite adherence
to the protocol, the length of stay (LOS) remains longer
than targeted. This study aimed to assess potential risk
factors for prolonged LOS and readmissions.
Methods The study was a prospective observation with a post-
hoc analysis of bariatric patients in a tertiary referral university
teaching hospital. Inclusion criteria were undergoing laparo-
scopic bariatric surgery. Exclusion criteria were occurrence of
perioperative complications, prior bariatric procedures, and lack
of necessary data. The primary endpoints were the evaluations
of risk factors for prolonged LOS and readmissions.
Results Median LOSwas 3 (2–4) days. LOS > 3 days occurred
in 145 (29.47%) patients, 79 after LSG (25.82%) and 66 after
LRYGB (35.48%; p = 0.008). Factors significantly prolonging
LOS were low oral fluid intake, high intravenous volume of
fluids administered on POD0, and every additional 50 km dis-
tance from habitual residence to bariatric center. The risk of
hospital readmission rises with occurrence of intraoperative ad-
verse events and low oral fluid intake on the day of surgery on.
Conclusions Risk factors for prolonged LOS are low oral fluid
intake, high intravenous volume of fluids administered on
POD0, and every additional 50 km distance from habitual res-
idence. Risk factors for hospital readmission are intraoperative
adverse events and low oral fluid intake on the day of surgery.
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Introduction
Nowadays, laparoscopic sleeve gastrectomy (LSG) and
laparoscopic gastric bypass (LRYGB) are becoming first-
line treatment for morbid obesity in Poland and worldwide,
with widely accepted low risk for postoperative morbidity
and low mortality [1–5]. In addition, treating patients in
accordance with enhanced recovery after surgery (ERAS)
protocols has reduced the length of stay (LOS) and de-
creased morbidity [6, 7]. Despite that, some patients with
successful adherence to the protocol and uneventful peri-
and post-operative period fail to meet discharge criteria
and remain a longer period of time than targeted LOS.
Shorter LOS may be associated with an increased rate of
readmissions, and in some patients it results in readmission
for variety of reasons [8–10].
The relationship between perioperative complications oc-
currence and prolonged LOS seems to be obvious, but the
interesting question is what is affecting LOS in uncompli-
cated patients. Therefore, we analyzed risk factors for
prolonged hospitalization and hospital readmission in order
to predict patients without complications who might require
longer hospital observation.
Aim
Study aim was to identify risk factors for prolonged length of
hospital stay and unplanned readmission after laparoscopic
sleeve gastrectomy and laparoscopic Roux-en-Y gastric bypass
among patients with uncomplicated postoperative course.
Methods
The study was a prospective observation with a post-hoc anal-
ysis of patients who underwent bariatric surgery in a tertiary
referral university teaching hospital. The indication for surgical
treatment was taken from the IFSO-EC and EASO guidelines:
body mass index (BMI) ≥ 35 kg/m2 with comorbidities or BMI
of ≥ 40 kg/m2 [11, 12]. The inclusion criteria were written
informed consent upon hospital admission acknowledging that
the outcomes of perioperative treatment and follow-up may be
analyzed retrospectively and used for research, age of 18 to
65 years, and eligibility for LSG or LRYGB. Exclusion criteria
were occurrence of perioperative complications, prior bariatric
procedures, and lack of necessary data. Study was designed
according to STROBE Statement [13].
Patients were treated in accordance with the principles of
multimodal ERAS pathway, including preoperative, intraop-
erative, and postoperative interventions [2, 6, 14–16].
Preoperative interventions included extensive perioperative
counseling, shortened fluid fasts, preoperative high protein
and carbohydrate drink, and optimized operating scheduling
times. Intraoperatively, the optimized bariatric anesthetic pro-
tocol was introduced with the use of multimodal analgesia.
There was no routine use of nasogastric tubes and
intraabdominal drains. Postoperative interventions included
early mobilization, analgesia without opioids, administration
of IPP-antagonist, early enteral feeding, and discharge plan-
ning. Anti-thrombotic prophylaxis was administered up to 14
postoperative days with the use of Enoxaparine. Detailed in-
formation on protocol used in our clinic is presented below:
1. Preoperative counseling and patient’s education
2. Pre-operative carbohydrate loading (400 ml of Nutricia
preOp® 2 h prior surgery)
3. Antithrombotic prophylaxis (Clexane® 40 mg sc.
starting in the evening prior surgery)
4. Antibiotic prophylaxis (preoperative Ceftriaxone 2 g iv
30–60 min. prior surgery)
5. Laparoscopic surgery
6. Balanced intravenous fluid therapy (< 2500 ml intrave-
nous fluids during the day of surgery, less than 150mmol
sodium). Indication for administration of i.v. fluids after
surgery: vomiting, insufficient oral fluid intake (less than
500 ml before 7:00 pm, 7 h after surgery), insufficient
diuresis (less than 500 ml of urine before 7:00 pm, 7 h
after surgery). The target is to not use intravenous fluids
in POD1. Fluids were given only if we observed absence
of sufficient functional recovery: vomiting, insufficient
oral fluid intake (less than 500 ml until 4:00 pm), insuf-
ficient diuresis, or biochemical symptoms of
rhabdomyolysis
7. No nasogastric tubes postoperatively
8. No drains left routinely
9. TAP block and bariatric anesthesia protocol
10. Avoiding opioids, multimodal analgesia (oral when pos-
sible—Paracetamol 4 × 1 g, Ibuprofen 2 × 200 mg,
Metamizole 2 × 500 mg, or Ketoprofen 2 × 100 mg);
routine use of ondansetron, metoclopramide, and
deksametazon at the end of the surgery
11. Postoperative oxygenation therapy (4–6 l/min)
12. Early oral feeding (oral nutritional supplement 4 h post-
operatively—Nutrcia Nutridrink® or Nestlé Impact®,
light hospital diet, and oral nutritional supplements on
the first postoperative day, full hospital diet in the second
postoperative day)
13. Early mobilization on the day of surgery (sitting on the
bed 2 h after surgery, breathing exercises with physio-
therapist, walking to the toilette, and walking along the
corridor (at least 150m) accompanied by an ERAS nurse
or a family member. Full mobilization on the first post-
operative day (getting out of bed, going to the toilette,
walking along the corridor without support of the nurse,
at least 4–6 h out of bed)
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On admission, every patient was informed about the target
length of stay of 3 days. Discharge criteria:
& Oral diet tolerance (solid food consumption, drinking at
least 1500 ml of fluids)
& No need for i.v. drugs or fluids
& Balanced diuresis
& Pain of low magnitude, manageable with oral pain killers
& No fever
& Properly healing surgical wounds
& Physical activity at a level similar to pre-surgery time
& No complications requiring in-hospital observation
& Other’s people help available in the first days after surgery
& Possibility to return to hospital when suspecting compli-
cation development (means to contact, transportation from
home)
Patients were scheduled for postoperative appointment
2 weeks after discharge, next 1 and 6 months after discharge.
Surgical techniques for LSG and LRYGB were standardized
in all cases to reduce study bias.
The primary endpoints were the evaluations of risk factors
for prolonged length of stay and of risk factors for
readmissions in the postoperative period in the group of pa-
tients without complications.
LOS was defined as the length of inpatient episode of care,
calculated from the day of admission to the day of discharge,
and based on the number of nights spent in hospital. The dis-
charge occurred regardless of the day of the week. Patients were
dichotomized into group of patients whose hospital stay was
shorter or equal to the target LOS (≤3 days) and group of pa-
tients with prolonged LOS, defined as total length of stay in
bariatric care unit longer than 3 days. Readmission was defined
as hospitalization after discharge from bariatric care unit related
to bariatric treatment within 30-days postoperative period.
Comparison of baseline patients data was done using
Student’s t test or Mann-Whitney’s test for quantitative vari-
ables, while χ2 with or without Yates’ correction were used for
qualitative variables. Univariate and multivariate logistic re-
gression models were built to assess influence of patient- and
treatment-related parameters on odds ratios (OR) with 95%
confidence intervals (95% CI) for prolonged hospital stay
and hospital readmissions. P value < 0.05 was considered
statistically significant. Data were analyzed using Statistica
version 12.0 PL (StatSoft Inc., Tulsa, Oklahoma, USA).
Quantitative data are expressed as mean ± standard deviation
or medians with interquartile range.
All procedures performed in studies involving human par-
ticipants were in accordance with the ethical standards of the
institutional and national research committee and with the 1964
Helsinki Declaration and its later amendments or comparable
ethical standards. The study was approved by the Bioethics
Committee of the Jagiellonian University.
Material
From April 2009 to July 2016, 543 patients were treated for
morbid obesity. Then, 492 patients met inclusion criteria and
were submitted to laparoscopic sleeve gastrectomy or laparo-
scopic Roux-en-Y gastric bypass [310 females, 182 males,
median age 42 (34–51) years] (Table 1). Flow chart of patients
in the study is shown in Fig. 1.
Results
Median length of hospital stay (LOS) was 3 (2–4) days. LOS
> 3 days occurred in 145 (29.47%) patients, 79 after LSG
(25.82%), and 66 after LRYGB (35.48%; p = 0.008). Factors
possibly prolonging length of hospital stay were analyzed in
univariate logistic regression models. Maximal preoperative
BMI > 51.50 kg/m2, LRYGB, operative time, intraoperative
adverse events, high intraoperative volume of administered
fluids, low postoperative oral fluid intake and diuresis, need
for Furosemide forced diuresis, high postoperative intravenous
fluid volume, postoperative tachycardia, occurrence of postop-
erative fever, postoperative nausea and vomiting, requirement
for additional pain medication, every 50 km distance between
place of residence and bariatric center were significantly related
to the risk of prolonged LOS (LOS > 3 days vs. ≤ 3 days)
(Table 2). Therefore, those possibly relevant factors were ana-
lyzed in multivariate logistic regression model (Table 3).
Table 1 Patients and groups baseline characteristics
Parameter All patients
492 (100%)
Females, n (%) 310 (63%)
Males, n (%) 182 (37%)
Median age, years (IQR) 42 (34–51)
Median maximal preoperative BMI, kg/m2 (IQR) 46.56 (42.89–51.50)
Median BMI on a day of operation, kg/m2 (IQR) 45.09 (41.31–49.74)
ΔBMI (IQR) 0.98 (0–2.42)
ASA class, n (%) 1 11 (2.30%)
2 333 (69.52%)
3 135 (28.18%)
Cardiovascular diseases, n (%) 87 (17.68%)
Hypertension, n (%) 335 (68.23%)
Prediabetes, n (%) 22 (4.47%)
Diabetes mellitus, n (%) 168 (34.29%)
Obstructive sleep apnea, n (%) 35 (7.11%)
Non-alcoholic fatty liver disease, n (%) 306 (62.45%)
Dyslipidemia, n (%) 278 (56.85%)
IQR interquartile range, ASA classAmerican Society of Anesthesiologists
physical status classification system
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Factors significantly prolonging LOS were low oral fluid
intake, high intravenous volume of fluids administered on
POD0, and every additional 50 km distance from habitual
residence to bariatric center.
Readmission rate in the study population was 5.89% (29
readmissions). Fourteen patients after LSG (4.58%) were
readmitted, while 15 after LRYGB (8.06%; p = 0.172)
(Table 4). Univariate logistic regression analyses revealed sta-
tistically significant impact of operative time, intraoperative
adverse events, intraoperative volume of administered fluids,
oral fluid intake, postoperative intravenous fluid administra-
tion, and prolonged LOS (> 3 days vs. ≤ 3 days) on the risk of
hospital readmission (Table 5). Multivariate logistic regres-
sion model revealed significant impact of occurrence of intra-
operative adverse events and low oral fluid intake on the day
of surgery on the risk of hospital readmission (Table 6).
Intraoperative adverse events which occurred in our unit are
presented in Table 7.
Discussion
We report outcomes of a study, where we sought to identify
risk factors for prolonged length of hospital stay, despite in-
stituted treatment according to modern model of perioperative
care (ERAS). In our unit, our aim is to discharge the patient
not as early as it is possible but as soon as patients reach full
functional recovery. We demonstrated that with every 100 ml
of oral fluid intake on the POD0, the risk for prolonged LOS
decreased by 23%. As for i.v. fluids on POD0, the need for
every 500 ml increased the risk for prolonged hospital stay
1.71 times. With every 50 km distance from the hospital to
place of residence, the odds for prolonged LOS increased 1.59
times. We revealed that occurrence of intraoperative adverse
events (after excluding patients with perioperative complica-
tions in study design) increased 4.2 times odds ratio for read-
mission. Additional data on which intraoperative events led to
readmission are presented in Table 7. It should be emphasized
that even though the result is statistically insignificant for par-
ticular types of events, the fact the readmissions occurred only
after BNeed for small intestine resection^ or BIntraoperatively
diagnosed staple line leakage^ should alert the surgeon about
possible readmission. High oral fluid intake on POD0 was
protective factor decreasing risk for readmission 0.54 times.
Length of stay varies among bariatric centers due to
differences in perioperative pathways and discharge
criteria. Recent study on predictors for LOS, which in-
cluded 9593 LRYGB, reported median length of stay of
2 days (range 0–544), in which 26% of patients required
> 3 days of hospitalization [17]. In a study by Dallal
et al., the hospital discharged 48% of bariatric patients
by postoperative day (POD) 1, 85% by POD 2, and
96% by POD 3 [18]. Other studies on this matter usually
reported LOS > 3 days as prolonged LOS, which is the
same threshold as we had [19–21]. Different treatment
protocols are administered nowadays for bariatric patients.
Assessed for eligibility (n=543) 
Excluded  (n=51) 
Revision procedure (n=9) 
Different procedure (n=1) 
Perioperative complications (n=41)
LOS >3 days (n=79) 
LOS ≤3 days (n=227)  
 Allocated to LSG (n=306)  Allocated to LRYGB (n=186) 
LOS >3 days (n=66) 
LOS ≤3 days (n=120)  
Allocation
Analysis
Admitted to bariatric surgery (n=492) 
Enrollment
Readmitted (n=14) 
Non-readmitted (n=290)  
Lost to follow-up (n=2) 
Readmitted (n=15) 
Non-readmitted (n=170)  
Lost to follow-up (n=1) 
Follow-up
Fig. 1 Study flowchart
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Table 2 Univariate logistic regression models for odds ratio of prolonged LOS (> 3 vs. ≤ 3 days)
Factors OR 95% CI P
Patient-related Sex (M = 0, F = 1) 0.91 0.61–1.35 0.629
Age (with every 1 year) 0.99 0.97–1.01 0.374
Age (> 51 vs. ≤ 51 years) 1.07 0.68–1.70 0.761
Maximal preoperative BMI (1 kg/m2) 1.03 0.99–1.06 0.056
Maximal preoperative BMI (> 51.50 vs. ≤ 51.50 kg/m2) 1.55 1.01–2.39 0.047
BMI on the day of operation (1 kg/m2) 1.02 0.99–1.06 0.119
BMI on the day of operation (> 49.74 vs. ≤ 49.74 kg/m2) 1.41 0.91–2.18 0.124
Co-morbidities ASA class (with every point) 1.36 0.91–2.04 0.133
Cardio-vascular diseases (yes = 1, no = 0) 1.60 0.98–2.60 0.058
Arterial hypertension (yes = 1, no = 0) 1.21 0.79–1.84 0.388
Prediabetes (yes = 1, no = 0) 1.39 0.57–3.39 0.470
Diabetes mellitus (yes = 1, no = 0) 1.25 0.84–1.88 0.271
Obstructive sleep apnea (yes = 1, no = 0) 1.27 0.61–2.63 0.518
Non-alcoholic fatty liver disease (yes = 1, no = 0) 0.94 0.63–1.40 0.752
Dyslipidemia (yes = 1, no = 0) 1.36 0.91–2.02 0.131
Malnutrition (yes = 1, no = 0) 1.42 0.92–2.19 0.113
Treatment-related Type of procedure (LRYGB vs. LSG) 1.58 1.06–2.35 0.023
Operative time (with every 1 min) 1.01 1.00–1.01 <0.001
Operative time (> 150 vs. ≤ 150 min) 2.05 1.29–3.24 0.002
Intraoperative adverse effects (yes = 1, no = 0) 3.99 1.51–10.53 0.005
Intraoperative fluid volume administered (500 ml) 1.52 1.24–1.87 <0.001
Postoperative period Oral fluid intake on POD0 (100 ml) 0.80 0.74–0.85 <0.001
Oral fluid intake on POD1 (100 ml) 0.88 0.85–0.91 <0.001
Oral fluid intake on POD2 (100 ml) 0.94 0.91–0.97 <0.001
Oral fluid intake on POD3 (100 ml) 1.08 0.88–1.32 0.464
Diuresis on POD0 (1000 ml) 1.85 1.44–2.40 <0.001
Diuresis on POD1 (1000 ml) 1.20 0.91–1.57 0.190
Diuresis on POD2 (1000 ml) 1.29 0.94–1.75 0.111
Diuresis on POD3 (1000 ml) 28.95 0.08–10,888 0.261
Furosemide forced diuresis (yes = 1, no = 0) 2.52 1.58–4.02 <0.001
Intravenous fluid intake on POD0 (yes = 1, no = 0) 1.04 0.68–1.59 0.851
Intravenous fluid volume on POD0 (500 ml) 1.55 1.04–2.31 0.032
Intravenous fluid intake on POD1 (yes = 1, no = 0) 4.89 2.87–8.35 <0.001
Intravenous fluid volume on POD1 (500 ml) 1.57 1.34–1.83 <0.001
Intravenous fluid intake on POD2 (yes = 1, no = 0) 8.44 5.06–14.06 <0.001
Intravenous fluid volume on POD2 (500 ml) 1.56 1.18–2.06 0.002
Heart rate on POD0 (with every 1/min) 1.01 0.99–1.03 0.452
Tachycardia on POD0 (yes = 1, no = 0) 9.82 1.08–89.19 0.042
Heart rate on POD1 (with every 1/min) 0.99 0.97–1.01 0.420
Tachycardia on POD1 (yes = 1, no = 0) 1.50 0.48–4.69 0.482
Heart rate on POD2 (with every 1/min) 1.01 0.99–1.03 0.591
Tachycardia on POD2 (yes = 1, no = 0) 2.04 0.50–8.32 0.319
Heart rate on POD3 (with every 1/min) 1.00 0.97–1.03 0.940
Tachycardia on POD3 (yes = 1, no = 0) 1.22 0.11–13.84 0.874
CPK (> 1000 vs. < 1000 U/L) 1.55 0.87–2.74 0.135
Postoperative fever (yes = 1, no = 0) 2.50 1.50–4.15 <0.001
Postoperative nausea and vomiting (yes = 1, no = 0) 2.57 1.19–5.57 0.016
Additional pain medication required (yes = 1, no = 0) 1.95 1.30–2.94 0.001
Distance between the hospital and place of residence (50 km) 1.18 1.08–1.28 <0.001
Italic entries reached significance of p < 0.05 as stated in methodology
ASA class American Society of Anesthesiologists physical status classification system, POD0 postoperative day 0, POD1 postoperative day 1, POD2
postoperative day 2, POD3 postoperative day 3, POD4 postoperative day 4, CPK creatine phosphokinase
OBES SURG (2018) 28:323–332 327
Many researchers reported bariatric procedures performed in
the fast-track surgery way; however, this requires additional
actions to prepare and carry on treatment within 24-h hospital
stay [22–24]. In our case, patients were admitted to the hospi-
tal in the afternoon prior to the operation day. Hospital stay
was planned for 3 days and patients were obligated to follow
criteria for discharge upon decision making. In summary,
comparison between different bariatric centers could be trou-
blesome, not only because of qualitative differences but also
due to the applied approach to the treatment protocol.
The overall readmission rate in a study by Lois et al.,
which included 95,294 patients after bariatric surgery, was
5.7% [19]. Recent study by Sippey et al. reported an
overall 30-day readmission rate after LSG or LRYGB of
5.1% [25]. Other authors reported readmission rates after
those two procedures in the range of 1.87–14.16% [18,
26–33]. Despite many authors reporting more common
readmissions after LRYGB compared with LSG [25, 27,
28, 34], one study documented higher rates after LSG
[19]. In our study, overall readmission rate was 5.89%.
According to other studies, patient-related factors associat-
ed with prolonged LOS were age, higher preoperative BMI,
male sex, number of preoperative comorbidities, and opera-
tive time [18, 35–38]. Regarding demographic factors in our
study, they were not significantly related to the risk of
prolonged LOS. Considering comorbidities, Carter et al. in a
Table 3 Multivariate logistic
regression models for odds ratio
of prolonged LOS (> 3 vs.
≤ 3 days)
OR 95% CI P
Maximal preoperative BMI (> 51.50 vs. ≤ 51.50 kg/m2) 1.11 0.39–3.13 0.849
Type of procedure (LRYGB vs. LSG) 0.74 0.25–2.21 0.590
Operative time (> 150 vs. ≤ 150 min) 1.11 0.36–3.38 0.859
Intraoperative adverse effects (yes = 1, no = 0) 1.88 0.37–9.49 0.439
Intraoperative fluid volume administered (500 ml) 0.75 0.45–1.24 0.255
Oral fluid intake on POD0 (100 ml) 0.77 0.67–0.88 <0.001
Intravenous fluid volume on POD0 (500 ml) 1.71 1.03–2.82 0.036
Diuresis on POD0 (1000 ml) 1.19 0.61–2.32 0.603
Furosemide forced diuresis (yes = 1, no = 0) 1.19 0.40–3.57 0.751
Tachycardia on POD0 (yes = 1, no = 0) 9.19 0.38–219.79 0.167
Postoperative fever (yes = 1, no = 0) 2.23 0.77–6.49 0.139
Postoperative nausea and vomiting (yes = 1, no = 0) 1.02 0.31–3.38 0.973
Additional pain medication required (yes = 1, no = 0) 0.88 0.36–2.15 0.775
Distance between the hospital and place of residence (50 km) 1.59 1.26–2.01 <0.001
Italic entries reached significance of p < 0.05 as stated in methodology
POD0 postoperative day 0
Table 4 Reasons for readmission
LSG LRYGB
Operation site hernia 2 (0.65%) 3 (1.61%)
Cholecystitis 2 (0.65%) 3 (1.61%)
Linea alba herniation 0 2 (1.08%)
Internal hernia (Petersen space hernia) 0 1 (0.54%)
Perforated gastric ulcer 0 1 (0.54%)
GI bleeding 0 2 (1.08%)
Perianal abscess 0 1 (0.54%)
Pulmonary thrombosis 0 1 (0.54%)
Gastroesophageal reflux disease 3 (0.98%) 0
Fever of undetermined origin 1 (0.33%) 0
Chronic diarrhea 1 (0.33%) 0
Suspected ileus 1 (0.33%) 0
Dysphagia 4 (1.31%) 0
Lower abdomen pain 0 1 (0.54%)
Total 14/306 (4.58%) 15/186 (8.06%)
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Table 5 Univariate logistic regression models of factors possibly affecting odds ratio of hospital readmission
Factors OR 95% CI P
Patient-related Sex (M = 0, F = 1) 0.76 0.35–1.66 0.495
Age (with every 1 year) 1.02 0.99–1.06 0.208
Age (> 51 vs. ≤ 51 years) 1.14 0.47–2.77 0.765
Maximal preoperative BMI (1 kg/m2) 1.05 0.99–1.10 0.094
Maximal preoperative BMI (> 51.50 vs. ≤ 51.50 kg/m2) 1.44 0.63–3.28 0.382
BMI on the day of operation (1 kg/m2) 1.03 0.97–1.09 0.404
BMI on the day of operation (> 49.74 vs. ≤ 49.74 kg/m2) 1.44 0.63–3.28 0.382
Co-morbidities ASA class (with every point) 1.54 0.69–3.43 0.287
Cardio-vascular diseases (yes = 1, no = 0) 1.93 0.82–4.56 0.130
Arterial hypertension (yes = 1, no = 0) 1.19 0.51–2.77 0.692
Prediabetes (yes = 1, no = 0) 2.79 0.77–10.10 0.117
Diabetes mellitus (yes = 1, no = 0) 0.91 0.40–2.06 0.823
Obstructive sleep apnea (yes = 1, no = 0) 0.48 0.06–3.67 0.478
Non-alcoholic fatty liver disease (yes = 1, no = 0) 0.93 0.42–2.02 0.847
Dyslipidemia (yes = 1, no = 0) 1.65 0.73–3.74 0.227
Malnutrition (yes = 1, no = 0) 1.57 0.66–3.74 0.304
Treatment-related Type of procedure (LRYGB vs. LSG) 1.70 0.79–3.65 0.176
Operative time (with every 1 min) 1.01 1.00–1.01 0.068
Operative time (> 150 vs. ≤ 150 min) 2.31 1.02–5.24 0.044
Intraoperative adverse effects (yes = 1, no = 0) 5.32 1.62–17.45 0.006
Intraoperative fluid volume administered (500 ml) 1.78 1.27–2.50 0.001
Postoperative period Oral fluid intake on POD0 (100 ml) 0.86 0.74–0.99 0.030
Oral fluid intake on POD1 (100 ml) 0.94 0.88–1.01 0.072
Oral fluid intake on POD2 (100 ml) 0.91 0.84–0.98 0.010
Oral fluid intake on POD3 (100 ml) 0.92 0.81–1.04 0.162
Diuresis on POD0 (1000 ml) 1.56 0.99–2.47 0.056
Diuresis on POD1 (1000 ml) 0.74 0.40–1.36 0.337
Diuresis on POD2 (1000 ml) 0.98 0.52–1.87 0.957
Diuresis on POD3 (1000 ml) 2.01 0.93–4.34 0.072
Furosemide-forced diuresis (yes = 1, no = 0) 0.78 0.33–1.87 0.577
Intravenous fluid intake on POD0 (yes = 1, no = 0) 0.88 0.35–2.21 0.781
Intravenous fluid volume on POD0 (500 ml) 0.05 0.004–0.68 0.023
Intravenous fluid intake on POD1 (yes = 1, no = 0) 1.54 0.59–4.03 0.379
Intravenous fluid volume on POD1 (500 ml) 1.19 0.96–1.47 0.113
Intravenous fluid intake on POD2 (yes = 1, no = 0) 2.31 0.89–5.96 0.083
Intravenous fluid volume on POD2 (500 ml) 0.95 0.63–1.42 0.791
Heart rate on POD0 (with every 1/min) 1.01 0.96–1.05 0.767
Tachycardia on POD0 (yes = 1, no = 0) 5.14 0.55–48.33 0.151
Heart rate on POD1 (with every 1/min) 1.00 0.96–1.05 0.832
Tachycardia on POD1 (yes = 1, no = 0) 1.67 0.21–13.57 0.628
Heart rate on POD2 (with every 1/min) 1.01 0.97–1.05 0.709
Tachycardia on POD2 (yes = 1, no = 0) 0.02 0.008–62.24 0.701
Heart rate on POD3 (with every 1/min) 1.01 0.95–1.07 0.776
Tachycardia on POD3 (yes = 1, no = 0) 6.94 0.57–84.03 0.126
CPK (> 1000 vs. < 1000 U/L) 2.19 0.85–5.67 0.105
Postoperative fever (yes = 1, no = 0) 1.15 0.38–3.52 0.804
Postoperative nausea and vomiting (yes = 1, no = 0) 1.59 0.35–7.19 0.547
Additional pain medication required (yes = 1, no = 0) 1.71 0.72–4.04 0.221
Distance between the hospital and place of residence (50 km) 0.91 0.73–1.13 0.389
Prolonged LOS (> 3 vs. ≤ 3 days) 2.57 1.19–5.56 0.016
Italic entries reached significance of p < 0.05 as stated in methodology
ASA class American Society of Anesthesiologists physical status classification system, POD0 postoperative day 0, POD1 postoperative day 1, POD2
postoperative day 2,POD3 postoperative day 3,POD4 postoperative day 4, LOS length of stay,CPK creatine phosphokinase, LOS length of hospital stay
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large study involving 500 hospitals in the National Surgical
Quality Improvement Program (NSQIP) database showed that
after gastric by-pass, longer hospitalization was predicted by
diabetes, chronic obstructive pulmonary disease, hemorrhagic
diathesis, chronic kidney disease, hypoalbuminemia, but with
no other patient-related factors [17]. Sun et al. showed that
patients with history of congestive heart failure, peripheral
vascular, and kidney diseases were more prone to have longer
LOS [39]. However, in our study, neither higher ASA class
nor the presence of other comorbidities was related to the risk
of prolonged LOS. We proved that in the end, LRYGB was
not significantly related to prolonging LOS in comparison
with LSG. Similar conclusions were found Weiner et al.
[40]. We failed to determine what caused the lack of influence
of patient’s health status or comorbidities on our endpoints.
We hypothesize that it may be caused by individualized peri-
operative care, which was proven in another surgical disci-
plines [7, 41–43]. In studies by Reames et al., Carter et al.,
and Dallall et al., researchers concluded that the longer was
the operative time, the greater was the risk for prolonged
length of stay [17, 18, 20]. The same relationship was found
in our study; however, a multivariate analysis revealed that it
was contributing less to the risk of prolonged LOS. Nossaman
et al. concluded that the volume of intravenous fluids
administered during laparoscopic bariatric surgery significant-
ly correlates to LOS and delays wound healing [37]. They
showed that lower volumes of intraoperative fluid were sig-
nificantly associated with longer LOS [37]. Contrary to that,
we observed that patients who required larger amounts of
intraoperative i.v. fluids were more prone to longer hos-
pital stay; however, this correlation was not shown in the
multivariate analysis. In our study, decreased amount of
postoperative oral fluid intake (on POD0), need for i.v.
fluids (POD0), and increasing distance between the hos-
pital and place of residence were significantly contribut-
ing to increased risk of prolonged hospital stay.
In numerous papers, we found significant correlations of
some patient-dependent factors and comorbidities on readmis-
sion rates, i.e., higher BMI and ASA class, diabetes mellitus,
cardio-vascular, respiratory, renal co-morbidities, and chronic
steroid intake, protein malnutrition were showed to be associ-
ated with increased risk of readmission [21, 25, 34, 35, 38,
39]. Treating patients in accordance to ERAS protocol proba-
bly contributed to non-significant relationship of preoperative
ASA class and comorbidities with the risk of postoperative
readmissions in our study [6, 7, 15, 16, 44]. We, as other
researchers did, determined that BMI was not found to be a
predictor of readmission [34, 45, 46].
Table 6 Multivariate logistic
regression model for hospital
readmission
OR 95% CI P
Operative time (> 150 vs. ≤ 150 min) 2.79 0.34–22.94 0.335
Intraoperative adverse effects (yes = 1, no = 0) 4.20 1.17–151.14 0.039
Intraoperative fluid volume administered (500 ml) 1.88 0.72–4.92 0.192
Oral fluid intake on POD0 (100 ml) 0.54 0.29–0.99 0.043
Intravenous fluid volume on POD0 (500 ml) 0.03 0.001–1.18 0.059
Prolonged LOS (> 3 vs. ≤ 3 days) 0.31 0.03–3.42 0.332
Italic entries reached significance of p < 0.05 as stated in methodology
POD0 postoperative day 0, POD3 postoperative day 3, LOS length of stay
Table 7 Intraoperative adverse
events All Readmitted Non-readmitted P
Total 18/492 (3.66%) 4/29 (13.79%) 14/463 (3%) 0.015
Need for small intestine resection 6 2 4 0.041
Intraoperatively diagnosed staple
line leakage
2 2 0 –
Inappropriate stapling that required
modification of technique
2 0 2 –
Small intestine perforation 2 0 2 –
Excessive intraoperative bleeding 2 0 2 –
Intraoperatively diagnosed stricture 1 0 1 –
Intestinal serosa rupture 1 0 1 –
Probe immobilized with stapler 1 0 1 –
Intubation failure, cancelation of procedure 1 0 1 –
Italic entries reached significance of p < 0.05 as stated in methodology
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In study by Sippey et al., the readmissions were higher after
LRYGB compared with LSG [25]. In another, patients who
underwent LRYGB had 60% higher risk for readmission in
the 30-day postoperative time period compared to those who
underwent LSG [34]. Contrary to this, we and Doumouras
et al. did not observe similar relationship [26]. Operative time
and intraoperative adverse events were also proved to increase
risk of readmission [34, 47]. Postoperative complications
were found to be associated with significant increase in
readmissions in study byKhorgami et al. and other researchers
[26, 34, 48–50]. In our study, multivariate analysis elicited
independent influence of intraoperative adverse events and
oral fluid intake on POD0 as factors associated with the risk
of readmission. Regarding the fact that one of the most
common reason for readmission after bariatric surgery is
nausea/vomiting (12.95% in study by Aman et al. [28]),
the decreased amount of oral fluid intake is a reasonable
risk factor for readmission. We came to similar conclu-
sions basing on our material.
Lois et al., Dallal et al., and Baker et al. concluded that in
case of patients with LOS > 3 days, the risk of readmission was
several times more greater than in on day hospitalizations [18,
19, 33]. Longer LOS was also a predictor of readmission in the
study by Sun et al. [39]. In our study, patients with prolonged
LOS (> 3 days) were 2.57 times more likely to be readmitted in
comparison with patients whose LOS was ≤ 3 days; however,
the result was only significant in the univariate analysis.
Generally, it has to be emphasized that the factors we found
to be increasing the risk of readmission are associated with first
24–48 after since the beginning of surgery. Early discharge is a
result of how patients manages the treatment during the early
hours. This way we are able to select patients who are at poten-
tially greater risk of readmission.
Limitation of the Study
The study did not focus on the potential differences arising
from the severity of diabetes. Further study on the relationship
between the severity of diabetes in bariatric patients and its
impact on LOS and postoperative course is needed.
Conclusion
Decreased oral fluid intake, need for increased i.v. fluid
administration on the day of surgery, and longer distance
from habitual residence to bariatric center are potential risk
factors for prolonged hospital stay. Intraoperative adverse
events increase risk for hospital readmission. Greater oral
fluid intake on the day of procedure was associated with
lower risk for readmission.
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